Equilateral Enterprises Intrinsic Value
Equilateral Enterprises (EQUILATERA) median intrinsic value is ₹4.95 from 7 valuation models (range ₹5–₹41), vs current price ₹16.50 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Analyse Equilateral Enterprises ownership pattern to track promoter, FII and institutional holdings.
EQUILATERA Valuation Methods Summary — DCF, Graham Number & P/E
Equilateral Enterprises intrinsic value across 7 models vs current price ₹16.50 — upside/downside and value range per method. Read Equilateral Enterprises dividend policy for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹4.95 | ₹3.96 - ₹5.94 | -70.0% | EPS: ₹0.10, Sector P/E: 12x |
| Book Value Method | asset | ₹9.17 | ₹8.25 - ₹10.09 | -44.4% | Book Value/Share: ₹9.17, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹33.00 | ₹29.70 - ₹36.30 | +100.0% | Revenue/Share: ₹45.00, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹41.25 | ₹33.00 - ₹49.50 | +150.0% | CF Growth: 8.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹4.95 | ₹4.46 - ₹5.45 | -70.0% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹4.95 | ₹4.46 - ₹5.45 | -70.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| Graham Defensive Method | conservative | ₹4.95 | ₹4.46 - ₹5.45 | -70.0% | EPS: ₹0.10, BVPS: ₹9.17 |
EQUILATERA Intrinsic Value vs Market Price — All Valuation Models
Equilateral Enterprises fair value range ₹5–₹41 vs current market price ₹16.50 across 7 valuation models. For current market price and key ratios, visit Equilateral Enterprises screener.
EQUILATERA Intrinsic Value Analysis — Undervalued or Overvalued?
Equilateral Enterprises median intrinsic value ₹4.95, current price ₹16.50 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of EQUILATERA?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Equilateral Enterprises (EQUILATERA) is ₹4.95 (median value). With the current market price of ₹16.50, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹4.95 to ₹41.25, indicating ₹4.95 - ₹41.25.
Is EQUILATERA undervalued or overvalued?
Based on our multi-method analysis, Equilateral Enterprises (EQUILATERA) appears to be trading above calculated value by approximately 70.0%.
EQUILATERA Financial Health — Key Ratios vs Industry Benchmarks
Equilateral Enterprises financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | -6.00 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Operating Margin | -4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.35x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
EQUILATERA Cash Flow Quality — Operating & Free Cash Flow
Equilateral Enterprises operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹7 Cr | ₹4 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-14 Cr | ₹-14 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |